Trial intelligence / Profile preview

Ketamine vs Neostigmine in Serratus Anterior Plane Block for Mastectomy

NCT05802979Phase 3Unknown

Sponsor
Ain Shams University
Start
Jan 2023
Primary completion
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ketamine and neostigmine in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Total Postoperative Nalbuphine Consumption at 24 hours. Status: unknown.

02

Drugs

ketamineneostigmine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05802979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05802979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call